Skip to main content
IBDT logo
IBDT
(NYSEARCA)
iShares iBonds Dec 2028 Term Corporate ETF
$25.19-- (--)
Loading... - Market loading

IBDT ETF: iShares iBonds Dec 2028 Term Corporate ETF - Price, Holdings & Analysis

iShares iBonds Dec 2028 Term Corporate ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$25.19 - $25.22
52-Week High$25.74
52-Week Low$25.14
Open$25.19
Volume485.86K
Average Volume (3M)612.66K
Assets (AUM)3.93B
Expense Ratio0.10%
Total Holdings722
Inception DateSep 17, 2018
1 Day Change0.08%
1 Month Change-0.04%
6 Month Change-0.83%
YTD Change-1.08%
1 Year Change-0.20%
52-Week Change-0.20%
5 Year Change-12.81%
50-Day MA$25.25
200-Day MA$25.40
RSI45.59
Stochastic %K33.33
Stochastic %D34.86
Annual Dividend$1.24
Dividend Yield4.92%
Last Dividend Ex-DateJun 1, 2026
Dividend Growth YoY6.68%

Frequently Asked Questions About iShares iBonds Dec 2028 Term Corporate ETF

What is the current price of IBDT?

The latest IBDT price is $25.19. The 52-week range is $25.14–$25.74. IBDT has returned -0.2% over the past 52 weeks.

What is the expense ratio for IBDT?

IBDT's annual expense ratio is 0.10%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Fixed Incomes in the ETF Screener.

Does IBDT pay dividends?

Yes, IBDT pays a 4.92% dividend yield. The last ex-dividend date was 2026-06-01. View full dividend history in the Dividends section.

What are the top holdings of IBDT?

IBDT's largest holdings are CVS Health Corp 4.3% (0.9%), Pfizer Investment Enterprises Pte Ltd. 4.45% (0.7%), Amgen Inc. 5.15% (0.7%) (combined weight: 2.3%). The fund holds 722 total positions. View the complete portfolio breakdown in the Holdings section.

How does IBDT compare to similar ETFs?

Compare IBDT (0.10% expense ratio, $3.93B AUM) against similar Fixed Incomes using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.